All clinical trials or randomized clinical trials comparing the efficacy of tirzepatide with long-acting or ultra - long-acting insulin for treating type 2 diabetes were included
Around 42 percent of the U.S
According to a small study, after GI symptoms, fatigue was the second-most common side effect, affecting 6.3% of patients
It is used as a supportive supplement for maintaining overall cellular health
As treatment options expand, care becomes more flexible, more personalized, and more accessible to people who were previously hesitant or unable to use injectable medications
Sublingual tirzepatide formulations are also emerging, and the tirzepatide sublingual dosage chart covers the adjusted dosing for this alternative administration route